Limited Dose Rate Brachytherapy Monotherapy: Inadequate for NCCN UIR Prostate Cancer Patients

2 years ago 91
The following is a summary of “LDR-Brachytherapy monotherapy appears unsuited for NCCN unfavorable intermediate-risk prostate cancer patients,” published...
Read Entire Article